Nkarta Inc is a biotechnology business based in the US. Nkarta Inc shares (NKTX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.53 – a decrease of 20.69% over the previous week. Nkarta Inc employs 159 staff and has a trailing 12-month revenue of around $385.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $2.53 |
|---|---|
| 52-week range | $2.45 - $16.24 |
| 50-day moving average | $4.26 |
| 200-day moving average | $6.97 |
| Wall St. target price | $16.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.70 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.7 from 2024-11-14
| 1 week (2024-11-08) | -15.36% |
|---|---|
| 1 month (2024-10-16) | -37.79% |
| 3 months (2024-08-16) | -46.75% |
| 6 months (2024-05-16) | -60.41% |
| 1 year (2023-11-16) | 14.65% |
|---|---|
| 2 years (2022-11-16) | -72.51% |
| 3 years (2021-11-16) | 18.17 |
| 5 years (2019-11-12) | N/A |
| Revenue TTM | $385 |
|---|---|
| Gross profit TTM | $-36,220,000 |
| Return on assets TTM | -16.96% |
| Return on equity TTM | -30.4% |
| Profit margin | 0% |
| Book value | $6.11 |
| Market Capitalization | $190.5 million |
TTM: trailing 12 months
We're not expecting Nkarta Inc to pay a dividend over the next 12 months.
Over the last 12 months, Nkarta Inc's shares have ranged in value from as little as $2.45 up to $16.24. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nkarta Inc's is 0.871. This would suggest that Nkarta Inc's shares are less volatile than average (for this exchange).
Nkarta, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen that is in Phase 1 clinical trial for the treatment of relapsed/refractory (r/r) non-hodgkin lymphoma, as well as for lupus nephritis. It also develops NKX101, a CAR NK product candidate targeting cells that display NKG2D ligands, which is in Phase I clinical trial for the treatment of r/r acute myeloid leukemia or higher risk myelodysplastic syndromes, as well as for solid tumors. In addition, the company develops NKX070, targeting the CD70 tumor antigen to treat solid and liquid tumors; and NK+T cell therapy for use in the treatment of oncology, autoimmune disease, or infectious disease. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.